Clinical Trials for Lexicon Pharmaceuticals

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Lexicon Pharmaceuticals

Clinical Trials (7)

CKM For Safe Use of SGLT2i in Type 1 Diabetes

PHASE3Not yet recruiting

52 participants

Started: Jul 1, 2026 · Completed: Dec 31, 2030

1 condition5 sponsors1 location

Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

EARLY_PHASE1Recruiting

20 participants

Started: Sep 2, 2025 · Completed: Sep 30, 2026

1 condition2 sponsors1 location

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

PHASE2Recruiting

320 participants

Started: Jan 28, 2025 · Completed: Oct 31, 2027

2 conditions3 sponsors15 locations

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

PHASE3Recruiting

150 participants

Started: Oct 31, 2024 · Completed: May 31, 2029

4 conditions24 sponsors18 locations

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

PHASE3Recruiting

500 participants

Started: Sep 24, 2024 · Completed: Aug 31, 2026

2 conditions1 sponsor89 locations

Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes

PHASE1/PHASE2Recruiting

24 participants

Started: Sep 9, 2024 · Completed: Jan 31, 2028

1 condition3 sponsors1 location

Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer

PHASE2Active, not recruiting

22 participants

Started: Apr 17, 2019 · Completed: Oct 1, 2024

5 conditions3 sponsors3 locations